Finch Therapeutics lands $53 mln Series C

Somerville, Massachusetts-based Finch Therapeutics Group Inc, a microbiome therapeutics company, has raised $53 million in Series C financing. The investors included OCV Partners, Susquehanna International Group, Symbiosis LLC, the Trans-Pacific Technology Fund, Avenir Growth Capital, Morgan Noble, Shumway Capital and Willett Advisors.

Source: Press Release